RENEE SCHROEDER: Open Payments
NPI 1932979549 · MITCHELL, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $771 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Corium, LLC | 2 | $13 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, Qelbree, AUSTEDO XR, Azstarys.
Industry payments across SD — which companies pay providers there.
